ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 175 filers reported holding ANI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,274,237 | +15.9% | 20,010 | +25.8% | 0.00% | – |
| Q1 2024 | $1,099,858 | +39.7% | 15,910 | +11.4% | 0.00% | – |
| Q4 2023 | $787,399 | -5.0% | 14,280 | 0.0% | 0.00% | – |
| Q3 2023 | $829,097 | +7.9% | 14,280 | 0.0% | 0.00% | – |
| Q2 2023 | $768,692 | +49.4% | 14,280 | +10.3% | 0.00% | – |
| Q1 2023 | $514,374 | -13.3% | 12,950 | -12.2% | 0.00% | – |
| Q4 2022 | $593,513 | +25.5% | 14,753 | +0.2% | 0.00% | – |
| Q3 2022 | $473,000 | +7.3% | 14,720 | -0.9% | 0.00% | – |
| Q2 2022 | $441,000 | +6.0% | 14,855 | +0.5% | 0.00% | – |
| Q1 2022 | $416,000 | -37.7% | 14,783 | +2.0% | 0.00% | – |
| Q4 2021 | $668,000 | +15.6% | 14,493 | -17.7% | 0.00% | – |
| Q3 2021 | $578,000 | -8.7% | 17,610 | -2.5% | 0.00% | – |
| Q2 2021 | $633,000 | -19.2% | 18,060 | -16.7% | 0.00% | – |
| Q1 2021 | $783,000 | +38.8% | 21,669 | +11.6% | 0.00% | – |
| Q4 2020 | $564,000 | +9.7% | 19,419 | +6.6% | 0.00% | – |
| Q3 2020 | $514,000 | -16.0% | 18,212 | -3.8% | 0.00% | – |
| Q2 2020 | $612,000 | +6.6% | 18,926 | +34.2% | 0.00% | – |
| Q1 2020 | $574,000 | -35.8% | 14,100 | -2.8% | 0.00% | -100.0% |
| Q4 2019 | $894,000 | -15.1% | 14,500 | +0.3% | 0.00% | 0.0% |
| Q3 2019 | $1,053,000 | -20.7% | 14,450 | -10.5% | 0.00% | 0.0% |
| Q2 2019 | $1,328,000 | +83.7% | 16,150 | +57.6% | 0.00% | – |
| Q1 2019 | $723,000 | +56.8% | 10,250 | 0.0% | 0.00% | – |
| Q4 2018 | $461,000 | -20.5% | 10,250 | 0.0% | 0.00% | – |
| Q3 2018 | $580,000 | -15.3% | 10,250 | 0.0% | 0.00% | – |
| Q2 2018 | $685,000 | +25.9% | 10,250 | +9.6% | 0.00% | – |
| Q1 2018 | $544,000 | -58.4% | 9,350 | -53.9% | 0.00% | -100.0% |
| Q4 2017 | $1,308,000 | +163.7% | 20,288 | +114.7% | 0.00% | – |
| Q3 2017 | $496,000 | +0.4% | 9,450 | -10.4% | 0.00% | – |
| Q2 2017 | $494,000 | +25.4% | 10,550 | +32.7% | 0.00% | – |
| Q1 2017 | $394,000 | -88.4% | 7,950 | -85.9% | 0.00% | -100.0% |
| Q4 2016 | $3,410,000 | -0.1% | 56,250 | +9.3% | 0.00% | 0.0% |
| Q3 2016 | $3,414,000 | +121.0% | 51,450 | +85.9% | 0.00% | +200.0% |
| Q2 2016 | $1,545,000 | +304.5% | 27,680 | +143.9% | 0.00% | – |
| Q1 2016 | $382,000 | -25.4% | 11,350 | 0.0% | 0.00% | – |
| Q4 2015 | $512,000 | +14.3% | 11,350 | 0.0% | 0.00% | – |
| Q3 2015 | $448,000 | -36.4% | 11,350 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $704,000 | +185.0% | 11,350 | +187.3% | 0.00% | – |
| Q1 2015 | $247,000 | -18.2% | 3,950 | -26.2% | 0.00% | – |
| Q4 2014 | $302,000 | +282.3% | 5,350 | +91.1% | 0.00% | – |
| Q3 2014 | $79,000 | -17.7% | 2,800 | 0.0% | 0.00% | – |
| Q2 2014 | $96,000 | +1500.0% | 2,800 | +1307.0% | 0.00% | – |
| Q1 2014 | $6,000 | +50.0% | 199 | 0.0% | 0.00% | – |
| Q4 2013 | $4,000 | +100.0% | 199 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | – | 199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 426,162 | $17,362,000 | 2.40% |
| Mesirow Financial Investment Management, Inc. | 6,542 | $267,000 | 1.68% |
| Global Alpha Capital Management Ltd. | 217,746 | $8,871,000 | 1.60% |
| Hawk Ridge Capital Management | 196,661 | $8,012,000 | 1.35% |
| 1492 Capital Management LLC | 25,070 | $1,021,000 | 1.22% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,437 | $11,588,000 | 0.75% |
| Regent Investment Management LLC | 40,579 | $1,653,000 | 0.68% |
| THB ASSET MANAGEMENT | 52,964 | $2,157,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 38,155 | $1,554,000 | 0.48% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $1,446,000 | 0.39% |